PCRX logo

Pacira BioSciences (PCRX) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$153.30 M
+$49.16 M+47.21%

December 31, 2023


Summary


Performance

PCRX Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPCRXbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$245.97 M
-$1.09 M-0.44%

September 30, 2024


Summary


Performance

PCRX Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPCRXbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

PCRX Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+47.2%+148.2%
3 y3 years+53.4%+8.5%
5 y5 years+15.7%+8.5%

PCRX Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-73.8%+47.2%-58.0%+592.0%
5 y5-year-73.8%+96.0%-58.0%+592.0%
alltimeall time-73.8%+2066.1%-58.0%+7170.6%

Pacira BioSciences Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$245.97 M(-0.4%)
Jun 2024
-
$247.05 M(+34.2%)
Mar 2024
-
$184.05 M(+20.1%)
Dec 2023
$153.30 M(+47.2%)
$153.30 M(+54.7%)
Sep 2023
-
$99.12 M(+14.2%)
Jun 2023
-
$86.81 M(+144.2%)
Mar 2023
-
$35.55 M(-65.9%)
Dec 2022
$104.14 M(-82.2%)
$104.14 M(-4.8%)
Sep 2022
-
$109.42 M(-10.4%)
Jun 2022
-
$122.06 M(-46.2%)
Mar 2022
-
$226.75 M(-61.3%)
Dec 2021
$585.58 M(+485.8%)
$585.58 M(+336.9%)
Sep 2021
-
$134.04 M(+26.7%)
Jun 2021
-
$105.77 M(+58.6%)
Mar 2021
-
$66.70 M(-33.3%)
Dec 2020
$99.96 M(+27.8%)
$99.96 M(-20.2%)
Sep 2020
-
$125.24 M(+59.4%)
Jun 2020
-
$78.55 M(+43.9%)
Mar 2020
-
$54.59 M(-30.2%)
Dec 2019
$78.23 M(-41.0%)
$78.23 M(-8.1%)
Sep 2019
-
$85.14 M(+42.5%)
Jun 2019
-
$59.74 M(-72.2%)
Mar 2019
-
$215.04 M(+62.3%)
Dec 2018
$132.53 M(+144.8%)
$132.53 M(-42.6%)
Sep 2018
-
$230.94 M(+97.6%)
Jun 2018
-
$116.87 M(+181.2%)
Mar 2018
-
$41.56 M(-23.2%)
Dec 2017
$54.13 M
$54.13 M(+106.5%)
Sep 2017
-
$26.22 M(-51.3%)
Jun 2017
-
$53.81 M(-50.6%)
DateAnnualQuarterly
Mar 2017
-
$108.97 M(+203.2%)
Dec 2016
$35.94 M(-36.9%)
$35.94 M(+47.1%)
Sep 2016
-
$24.44 M(-3.4%)
Jun 2016
-
$25.31 M(-27.7%)
Mar 2016
-
$35.03 M(-38.5%)
Dec 2015
$56.98 M(+51.9%)
$56.98 M(+86.7%)
Sep 2015
-
$30.52 M(-6.7%)
Jun 2015
-
$32.72 M(-20.0%)
Mar 2015
-
$40.90 M(+9.0%)
Dec 2014
$37.52 M(+199.8%)
$37.52 M(+111.3%)
Sep 2014
-
$17.76 M(-83.6%)
Jun 2014
-
$108.20 M(+476.7%)
Mar 2014
-
$18.76 M(+49.9%)
Dec 2013
$12.52 M(+23.6%)
$12.52 M(+269.9%)
Sep 2013
-
$3.38 M(-60.8%)
Jun 2013
-
$8.63 M(-67.2%)
Mar 2013
-
$26.27 M(+159.5%)
Dec 2012
$10.13 M(-78.1%)
$10.13 M(+16.3%)
Sep 2012
-
$8.71 M(-59.4%)
Jun 2012
-
$21.45 M(-14.9%)
Mar 2012
-
$25.21 M(-45.4%)
Dec 2011
$46.17 M(+76.7%)
$46.17 M(+181.5%)
Sep 2011
-
$16.40 M(-40.2%)
Jun 2011
-
$27.45 M(-53.7%)
Mar 2011
-
$59.33 M(+127.0%)
Dec 2010
$26.13 M(+269.3%)
$26.13 M(+88.7%)
Sep 2010
-
$13.85 M(+12.1%)
Jun 2010
-
$12.35 M(+74.6%)
Dec 2009
$7.08 M(-42.9%)
$7.08 M
Dec 2008
$12.39 M
-

FAQ

  • What is Pacira BioSciences annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Pacira BioSciences?
  • What is Pacira BioSciences annual cash & cash equivalents year-on-year change?
  • What is Pacira BioSciences quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Pacira BioSciences?
  • What is Pacira BioSciences quarterly cash and cash equivalents year-on-year change?

What is Pacira BioSciences annual cash & cash equivalents?

The current annual cash & cash equivalents of PCRX is $153.30 M

What is the all time high annual cash & cash equivalents for Pacira BioSciences?

Pacira BioSciences all-time high annual cash & cash equivalents is $585.58 M

What is Pacira BioSciences annual cash & cash equivalents year-on-year change?

Over the past year, PCRX annual cash & cash equivalents has changed by +$49.16 M (+47.21%)

What is Pacira BioSciences quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of PCRX is $245.97 M

What is the all time high quarterly cash and cash equivalents for Pacira BioSciences?

Pacira BioSciences all-time high quarterly cash and cash equivalents is $585.58 M

What is Pacira BioSciences quarterly cash and cash equivalents year-on-year change?

Over the past year, PCRX quarterly cash and cash equivalents has changed by +$146.85 M (+148.15%)